首页> 美国卫生研究院文献>BMC Medicine >The hundred person wellness project and Google’s baseline study: medical revolution or unnecessary and potentially harmful over-testing?
【2h】

The hundred person wellness project and Google’s baseline study: medical revolution or unnecessary and potentially harmful over-testing?

机译:一百人健康计划和Google的基线研究:医疗革命还是不必要的可能有害的过度测试?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Hundred Person Wellness Project is an ambitious pilot undertaking, which aims to intensely monitor 100 individuals over 10 months. Patients with abnormal findings will be treated, in hopes that this early intervention will avoid, or delay, symptomatic disease. Google’s “Baseline Study” is of similar scope and will enroll 10,000 people over 2 to 3 years. I here speculate that these approaches will likely not be effective in preventing disease, but instead, lead to unnecessary and potentially harmful interventions. Examples from the cancer screening experience over the last 30 years are provided, which show that intensive testing may uncover indolent disease or incidental findings which, when treated, may cause more harm than good. Additional examples show that aggressive treatments for cancer and other diseases do not always lead to better patient outcomes. I conclude that the recent advances in omics provide us with unprecedented opportunities for high content clinical testing, but such testing should be used with caution to avoid the harmful consequences of over-diagnosis and over-treatment. Despite the detailed rebuttals by Hood and colleagues in another commentary in BMC Medicine, time will show the actual benefits and harms of these ambitious initiatives.Please see related commentary:
机译:百人健康计划是一项雄心勃勃的试点事业,旨在在10个月内对100个人进行严格监控。有异常发现的患者将得到治疗,希望这种早期干预能够避免或延迟症状性疾病。 Google的“基线研究”的范围类似,将在2-3年内招募10,000人。我在这里推测,这些方法可能无法有效地预防疾病,但会导致不必要和潜在有害的干预。提供了过去30年的癌症筛查经验中的示例,这些示例表明,强化测试可能会发现惰性疾病或偶然发现,这些疾病或偶然发现在接受治疗时,可能造成弊大于利。其他示例表明,针对癌症和其他疾病的积极治疗并不总是能带来更好的患者预后。我得出的结论是,组学的最新进展为我们提供了进行高含量临床测试的前所未有的机会,但是应谨慎使用此类测试,以避免过度诊断和过度治疗的有害后果。尽管Hood和同事在BMC Medicine的另一篇评论中进行了详细的反驳,但时间将显示出这些雄心勃勃的举措的实际利弊,请参见相关评论:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号